The Impact of Antimicrobial Therapy on the Development of Microbiota in Infants
Authors:
- Tatiana PriputnevichTPTatiana Priputnevich
- Pavel DenisovPDPavel Denisov
- Ksenia ZhigalovaKZKsenia Zhigalova
- Vera MuravievaVMVera Muravieva
- Natalia ShabanovaNSNatalia Shabanova
- Alexey GordeevAGAlexey Gordeev
- Viktor ZubkovVZViktor Zubkov
- Bayr BembeevaBBBayr Bembeeva
- Elena IsaevaEIElena Isaeva
- Anastasia NikolaevaANAnastasia Nikolaeva
- Gennady SukhikhGSGennady Sukhikh
Open Access
- 9 December 2025
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 14 (12) , 1245
Abstract
Background. The establishment and diversity of the gut microbiota during early childhood are fundamental for immune regulation and metabolic processes, with factors such as prematurity, delivery method, antibiotic treatment, and breastfeeding significantly impacting microbiome development and potential health outcomes. Objectives/Methods. This comparative study examined the gut microbiota composition in children aged 6–8 and 9–12 months, born via spontaneous labor at ≥38 weeks’ gestation, who either did not receive antibacterial therapy or required beta-lactam antibiotics. The composition of the colonic microbiota was analyzed in these fecal samples using a quantitative real-time PCR (qRT-PCR). Results. Significant differences in microbiota composition were observed between groups. Children treated with antibiotics exhibited a statistically significant reduction in alpha diversity indices (Shannon and Simpson), along with decreased colonization of key functionally important microorganisms, including obligate anaerobic bacteria such as Faecalibacterium prausnitzii, Clostridium leptum, Bacteroides spp., and metabolically active Bifidobacteria (B. bifidum, B. breve, B. longum). Conclusions. These microbiota alterations may adversely affect child health by diminishing microbial balance and functional potential, especially during this critical period of immune and metabolic development. The decline in anti-inflammatory, short-chain fatty acid-producing bacteria elevates the risk for allergic, atopic, dysbiotic, and metabolic conditions. Recognizing these impacts underscores the importance of strategies to supports microbiota restoration after antibiotic use, such as probiotics, prebiotics, and dietary interventions. Further research should focus on microbiota recovery dynamics to facilitate early intervention and optimize pediatric health outcomes. Overall, understanding antibiotic effects on gut microbiota can guide more judicious treatment approaches, reducing long-term health risks.Keywords
This publication has 59 references indexed in Scilit:
- Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in childrenWorld Journal of Pediatrics, 2024
- Impact of antibiotics on the human microbiome and consequences for host healthMicrobiologyopen, 2022
- Antibiotic exposure and adverse long-term health outcomes in children: A systematic review and meta-analysisJournal of Infection, 2022
- Association of Infant Antibiotic Exposure With Childhood Health OutcomesMayo Clinic Proceedings, 2020
- The effect of antibiotics on the composition of the intestinal microbiota - a systematic reviewJournal of Infection, 2019
- The Human Microbiome and Child Growth – First 1000 Days and BeyondTrends in Microbiology, 2019
- Review: Maternal health and the placental microbiomePlacenta, 2017
- Evaluation of the effects of intrapartum antibiotic prophylaxis on newborn intestinal microbiota using a sequencing approach targeted to multi hypervariable 16S rDNA regionsApplied Microbiology and Biotechnology, 2016
- Dynamics and Stabilization of the Human Gut Microbiome during the First Year of LifeCell Host & Microbe, 2015
- Microbiota in Pediatric Inflammatory Bowel DiseaseThe Journal of Pediatrics, 2010